Xenikos Enrolls First Patient in Global Pivotal Phase 3 Study Evaluating T-Guard® in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease

Press/Media

Period	28 Jun 2022

Media coverage

Title	Xenikos Enrolls First Patient in Global Pivotal Phase 3 Study Evaluating T-Guard® in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease
Media name/outlet	Asian Hospital & Healthcare Management
Country/Territory	India
Date	28/06/22
URL	https://www.asianhhm.com/pressreleases/xenikos-enrolls-first-patient-in-global-pivotal-phase-3-study-evaluating-t-guard
Persons	John Levine